Immunogenomic profiling of lung adenocarcinoma reveals poorly differentiated tumors are associated with an immunogenic tumor microenvironment-Reference-Cited by-同舟云学术

Immunogenomic profiling of lung adenocarcinoma reveals poorly differentiated tumors are associated with an immunogenic tumor microenvironment

Published:2022-10 Issue: Volume:172 Page:19-28
ISSN:0169-5002
Container-title:Lung Cancer
language:en
Short-container-title:Lung Cancer

Author:

Akhave Neal^ORCID,Zhang Jiexin,Bayley Erin,Frank Meredith,Chiou Shin-Heng,Behrens Carmen,Chen Runzhe,Hu Xin,Parra Edwin Roger,Lee Won-Chul,Swisher Stephen,Solis Luisa,Weissferdt Annikka,Moran Cesar,Kalhor Neda,Zhang Jianhua,Scheet Paul,Vaporciyan Ara A.,Sepesi Boris,Gibbons Don L.,Heymach John V.,Lee Jack J.,Wistuba Ignacio I.,Andrew Futreal P.,Zhang Jianjun,Fujimoto Junya,Reuben Alexandre^ORCID

Publisher

Elsevier BV

Subject

Cancer Research,Pulmonary and Respiratory Medicine,Oncology

Reference49 articles.

1. Annual report to the nation on the status of cancer, part I: National cancer statistics;Henley;Cancer,2020

2. Cancer Statistics, 2021;Siegel;CA Cancer J. Clin.,2021

3. NCCN Guidelines Insights: Non-Small Cell Lung Cancer, Version 2.2021;Ettinger;J. Natl. Compr. Canc. Netw,2021

4. NCCN Guidelines Insights: Small Cell Lung Cancer, Version 2.2018;Kalemkerian;J Natl. Compr. Canc. Netw.,2018

5. Cancer Genome Atlas Research N. Comprehensive molecular profiling of lung adenocarcinoma. Nature 2014;511:543-50.

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Prognostic implications, genomic and immune characteristics of lung adenocarcinoma with lepidic growth pattern;Journal of Clinical Pathology;2024-08-03

2. Differential Gene Expression of Tumors Undergoing Lepidic-Acinar Transition in Lung Adenocarcinoma;2024-03-20

3. Spatial transcriptomics reveals heterogeneity of histological subtypes between lepidic and acinar lung adenocarcinoma;Clinical and Translational Medicine;2024-02

4. Prognostic value of predominant subtype in pathological stage II–III lung adenocarcinoma with epidermal growth factor receptor mutation;Lung Cancer;2024-02

5. PD‐L1 expression in resected lung adenocarcinoma: prevalence and prognostic significance in relation to the IASLC grading system;Histopathology;2024-01-30